Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Cancer, Papillary 1Myasthenia Gravis 1Kidney Neoplasms 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Mass Spectrometry 4Immunohistochemistry 3Psychiatric Rehabilitation 2Gene Expression Profiling 2Chromatography, Liquid 2Chromatography, High Pressure Liquid 2Watchful Waiting 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Radiosurgery 1Molecular Diagnostic Techniques 1Mastectomy, Segmental 1Mastectomy 1Genotype 1Follow-Up Studies 1Fluorescent Antibody Technique 1Chromatin Immunoprecipitation Sequencing 1Biopsy, Needle 1Biopsy, Fine-Needle 1Anesthesia, General 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Carcinoma In Situ × Genotype × Clear all
NCT05755269 2026-05-01

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Mayo Clinic

Terminated
19 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡